PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation.

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Programmed cell death 1 (PD-1) is an immune-checkpoint receptor crucial for T cell regulation.
• PD-1 blockade demonstrates significant clinical efficacy across various cancer types.
• The precise mechanisms by which PD-1 influences T cell gene expression remain incompletely understood.

Purpose of the Study:

• To elucidate how PD-1 signaling impacts the transcriptome of T cells following T cell receptor (TCR) activation.
• To investigate the differential sensitivity of TCR-inducible genes to PD-1-mediated inhibition.
• To identify molecular features that dictate the sensitivity of genes to PD-1.

Main Methods:

• Quantification of gene expression changes in response to varying TCR signal strengths.
• Determination of the half maximal effective concentration (EC50) for PD-1 inhibition across different genes.
• Analysis of promoter regions, including transcription factor binding motifs and CpG frequency, to correlate with gene sensitivity.

Main Results:

• Significant heterogeneity in PD-1 sensitivity was observed among genes induced by TCR activation.
• Genes promoting T cell survival and proliferation showed high expression efficiency and resistance to PD-1 inhibition.
• Genes encoding cytokines and effector molecules were less efficiently expressed and highly sensitive to PD-1 inhibition.
• Promoter characteristics, such as transcription factor binding motifs and CpG frequency, were found to influence gene sensitivity (EC50) to PD-1.

Conclusions:

• PD-1 calibrates T cell transcriptomes in a manner dependent on TCR signal strength.
• Differential gene sensitivity to PD-1 shapes the functional output of T cell populations.
• Understanding these regulatory mechanisms provides insights into optimizing cancer immunotherapy.